The Mylan Brand of Clozapine was approved by the Food and Drug Administration (FDA) in 1999 as an affordable alternative to brand name clozapine (Clozaril^®*).¹ Since then, The Mylan Brand of Clozapine has been dispensed over a million times to help patients with schizophrenia control their symptoms and move on with life.²

This booklet helps answer common questions that patients and/or their family and friends may ask about schizophrenia and The Mylan Brand of Clozapine.  Click here if you would like to download a PDF version.

*Registered trademark of Novartis Pharmaceuticals Corporation.

References 1.  Data on file, Mylan Pharmaceuticals. 2. IMS National Prescription Audit, March 2005.